Amnesty calls out Cellebrite DI (CLBT) for spy tech misuse in Serbia
Cellebrite DI has come under pressure after an allegation that its tech was used for unethical practices in Serbia.
Cellebrite Di Ltd. (CLBT)
Market is closed
News
- 1 - 10
- Next >>
10 Emerging AI Stocks You Should Keep on Your Radar
As reported by CNBC on November 13, OpenAI’s "blueprint for U.S. AI infrastructure" outlines plans for AI economic zones, utilizing the U.S.
Is Cellebrite (CLBT) Poised to Develop And Sell The Next Generation Of AI Analytics Tools?
Greenhaven Road Capital, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q3 2024 Earnings Call Transcript
Operator: Welcome to the Cellebrite Third Quarter 2024 Financial Results Conference Call.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Cellebrite Second Quarter 2024 Financial Results Conference Call.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q1 2024 Earnings Call Transcript
Operator: Welcome to the Cellebrite First Quarter 2024 Financial Results Conference Call.
Should You Hold Cellebrite (CLBT)?
Greenhaven Road Capital, an investment management company, released its first quarter 2024 investor letter. A copy of the same can be downloaded here.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q4 2023 Earnings Call Transcript
Cellebrite DI Ltd. beats earnings expectations. Reported EPS is $0.11, expectations were $0.06. Cellebrite DI Ltd.
Cellebrite (CLBT) Benefitting from Increased Data Volume
Greenhaven Road Capital, an investment management company, released its fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Light Street Capital Returned 46% in 2023: Top 15 Picks
In this piece, we will take a look at Light Street Capital returned 46% in 2023: top 15 picks.
- 1 - 10
- Next >>
Billionaire Hedge Funds
